{"result": "(\"entity\"<|>EDIC<|>EVENT<|>The EDIC study is a long-term follow-up of patients with type 1 diabetes who were initially part of the DCCT study, focusing on mortality and complications over 27 years.)\n##\n(\"entity\"<|>DCCT<|>EVENT<|>The Diabetes Control and Complications Trial (DCCT) was a pivotal study that established the benefits of intensive diabetes management in type 1 diabetes patients.)\n##\n(\"entity\"<|>DM1<|>EVENT<|>DM1 refers to Type 1 Diabetes, a chronic condition where the pancreas produces little or no insulin, requiring lifelong management.)\n##\n(\"entity\"<|>GUBITOSI-KLUG RA<|>PERSON<|>Gubitosi-Klug RA is a researcher associated with the DCCT/EDIC Research Group, contributing to studies on diabetes management and outcomes.)\n##\n(\"entity\"<|>LACHIN JM<|>PERSON<|>Lachin JM is a researcher involved in the DCCT/EDIC Research Group, focusing on long-term outcomes of diabetes treatment.)\n##\n(\"entity\"<|>NATHAN DM<|>PERSON<|>Nathan DM is a prominent researcher in diabetes care, part of the DCCT/EDIC Research Group, studying diabetes complications and management.)\n##\n(\"entity\"<|>AACE<|>ORGANIZATION<|>The American Association of Clinical Endocrinologists (AACE) is an organization that provides guidelines and recommendations for diabetes treatment and management.)\n##\n(\"entity\"<|>DIABETES CARE<|>ORGANIZATION<|>Diabetes Care is a journal that publishes research and studies related to diabetes management and treatment outcomes.)\n##\n(\"relationship\"<|>EDIC<|>DCCT<|>EDIC is a follow-up study to the DCCT, examining long-term outcomes in patients who participated in the initial trial<|>8)\n##\n(\"relationship\"<|>GUBITOSI-KLUG RA<|>EDIC<|>Gubitosi-Klug RA is a researcher contributing to the findings and analysis of the EDIC study<|>7)\n##\n(\"relationship\"<|>LACHIN JM<|>EDIC<|>Lachin JM is involved in the research and analysis of the EDIC study outcomes<|>7)\n##\n(\"relationship\"<|>NATHAN DM<|>EDIC<|>Nathan DM is a key researcher in the EDIC study, focusing on diabetes management and outcomes<|>7)\n##\n(\"relationship\"<|>AACE<|>DIABETES CARE<|>AACE provides guidelines that are often referenced in studies published in Diabetes Care<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: cualquier causa.\nC. Que la mortalidad por cualquier causa se redujo en un 33%, tras 27 años de seguimiento, en el grupo de tratamiento intensivo en comparación con el grupo de tratamiento convencional.\nD. Que la mortalidad por cualquier causa fue menor en el grupo de tratamiento intensivo, pero tras 27 años de seguimiento la mortalidad global se igualó en ambos grupos.\n\n### COMENTARIO\n\nEl estudio EDIC constituye el seguimiento a largo plazo de la mayor parte de los pacientes con DM1 incluidos inicialmente en el estudio DCCT (1.394 individuos, 97% de la cohorte inicial). Al no existir intervención, el control metabólico conseguido (HbA1c del 7% en el grupo de control intensivo y del 9% en el grupo control a los 6,5 años de media) fue igualándose en ambas ramas hasta una HbA1c del 8%, a pesar de lo cual se mantuvieron los resultados iniciales positivos a lo largo del tiempo (seguimiento a 20 años en el estudio EDIC). Así, en el grupo de tratamiento intensivo se observó una menor incidencia y progresión de la retinopatía diabética (descenso del 53-56%), de la micro/macroalbuminuria incidente (reducciones del 59/84%), una mejoría en la tasa de filtrado glomerular (50%) y una menor incidencia de hipertensión arterial (20%).\n---\n# DIABETES 2\n\nEl control intensivo (durante 6,5 años) influyó en los resultados cardiovasculares en el seguimiento posterior (a los 20 años de haber finalizado la intervención), tanto en la arteriosclerosis subclínica (menor grosor íntima-media carotídea, menor calcificación coronaria, etc.) como en los eventos cardiovasculares (infarto agudo de miocardio, accidente vascular cerebral y muerte cardíaca).\n\nEn cuanto a la mortalidad, en este período de tiempo ocurrieron 107 defunciones, de las que 64 correspondieron al grupo convencional y 43, al grupo de tratamiento intensivo, siendo la diferencia absoluta de riesgo de -109 por 100.000 pacientes/año (IC 95% -218 a -1) con menor mortalidad por cualquier causa en el grupo intensivo, con un hazard ratio (HR) de 0,67 (IC 95% 0,46-0,99, p = 0,045). Concluyen que tras 27 años de seguimiento de pacientes con DM1, después de una terapia intensiva durante 6,5 años, se constató una modesta disminución de la mortalidad por cualquier causa del grupo inicialmente intensivo respecto al grupo de tratamiento convencional.\n\nAunque la mortalidad atribuida a hipoglucemia fue mayor en el grupo de tratamiento intensivo (11,3 %) comparado con el grupo convencional (6,1%), el beneficio de menor mortalidad en el grupo de tratamiento intensivo se mantuvo.\n\nReferencias:\n- Gubitosi-Klug RA; DCCT/EDIC Research Group. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions. Diabetes Care. 2014;37(1):44-9.\n- Lachin JM, Orchard TJ, Nathan DM; DCCT/EDIC Research Group. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37(1):39-43.\n- Writing Group for the DCCT/EDIC Research Group, Orchard TJ, Nathan DM, Zinman B, Cleary P, Brillon D, Backlund JY, Lachin JM. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA. 2015;313(1):45-53.\n\n## 2.5 Tratamiento\n\n### 55 En el documento sobre el tratamiento de la diabetes que propone la American Association of Clinical Endocrinologists (AACE), en su actualización del año 2017, se establecen unos aspectos de estilo de vida que es preciso tener en cuenta con el objetivo de reducir el riesgo cardiovascular del paciente diabético. Señale aquel que no se indica en dicho documento:\n\nA. Actividad física regular.\nB. Abstención absoluta de la ingesta de bebidas alcohólicas.\nC. Una suficiente cantidad de horas de sueño.\nD. Cese del hábito de fumar y del uso de productos relacionados con el tabaco.\n\nCOMENTARIO\n\nLos componentes clave de la terapia de estilo de vida incluyen terapia de nutrición médica, actividad física regular, suficientes horas de sueño, apoyo conductual y abandono del hábito de fumar, evitando todos los productos de tabaco.\n\nNumerosos estudios han demostrado que la ingesta moderada de alcohol se asocia con una menor incidencia de enfermedades cardíacas y mortalidad cardiovascular.\n\nReferencias:\n- Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004;38:613-9.\n- Costanzo S, Di\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}